首页 › 期刊 › 医学 › Metabolic Syndrome and Related Disorders
Metabolic Syndrome and Related Disorders
出版商:SAGE Publications · ISSN:1540-4196, 1557-8518 · 国家/地区:US · 类型:journal · 官网:https://www.liebertpub.com/loi/met
研究主题:Diabetes, Cardiovascular Risks, and Lipoproteins · Adipokines, Inflammation, and Metabolic Diseases · Liver Disease Diagnosis and Treatment · Obesity, Physical Activity, Diet · Diet, Metabolism, and Disease
数据覆盖:10 个公开学术数据源交叉核验(crossref、fqb、jcr、openalex、scimago、submission、wikidata、xr、cwts、jufo)。
数据来源与实体核验
期刊官网 · OpenAlex 期刊实体 · Wikidata 期刊实体
核心指标
- 影响因子(JCR 2025):1.600
- JCR 分区:Q4(MEDICINE, RESEARCH & EXPERIMENTAL)
- 中科院分区(2025):医学 4区,大类排名 4192/5603;小类:MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 4区,排名 147/188
- 新锐分区(2026):医学 4区
- SJR:0.548(Q2),2025 年,United States
- CWTS 2025:SNIP 0.537 · IPP 1.944 · 自引率 0.4%
- JUFO 出版渠道等级:芬兰 1 · 挪威 1 · 丹麦 1
- h-index:74
- i10 指数:765
- 近两年篇均被引:1.60
- 载文量 1594 · 总被引 33965
- Crossref DOI 总量:1576,近期 191
逐年趋势
- 近年影响因子:2021 2.36 → 2022 2.1 → 2023 1.3 → 2024 1.7 → 2025 1.6
- 近年 SJR:2021 0.611(Q2) → 2022 0.613(Q2) → 2023 0.552(Q2) → 2024 0.52(Q3) → 2025 0.548(Q2)
投稿参考
- 提供 LaTeX 投稿模板(sagej.cls)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- MMWR Surveillance Summaries — IF 96.9 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Signal Transduction and Targeted Therapy — IF 81.2 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
常见问题
《Metabolic Syndrome and Related Disorders》的影响因子是多少?
根据 JCR 2025 年数据,《Metabolic Syndrome and Related Disorders》的最新影响因子(IF)为 1.600。
《Metabolic Syndrome and Related Disorders》是几区期刊?
《Metabolic Syndrome and Related Disorders》中科院分区(2025年版)为医学4区,JCR 分区为 Q4。
本刊近期代表论文
- Sterol Regulatory Element-Binding Proteins and Metabolic Diseases: Mechanisms, Implications, and Therapeutic Strategies (2025 · 被引 6)
- Analysis of Health-Related Quality of Life and Its Influencing Factors Among Patients with Non-Alcoholic Fatty Liver Disease in Hangzhou, China: A Cross-Sectional Study (2025 · 被引 2)
- Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease (2022 · 被引 35)
- Prevalence of Hepatic Steatosis and Fibrosis in the United States (2022)
- Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity (2020 · 被引 175)
- Triglyceride-Glucose Index and Related Parameters Predicted Metabolic Syndrome in Nigerians (2020 · 被引 166)